U of A virologist David Evans (right) and research associate Ryan Noyce are teaming up with U.S.-based Tonix Pharmaceuticals to develop and test a vaccine against COVID-19, targeting the « spike » protein the coronavirus uses to enter cells and cause infection. (Photo: Melissa Fabrizio)

U of A researchers and Tonix Pharmaceuticals race to develop and test candidate vaccines for COVID-19

Posted on

Read More Impact Stories

Posté le
Cet article n’est disponique qu’en anglais. B.C. researchers identify gene that fuels aggressive childhood cancers – UBC Faculty of Medicine [...]
Posté le
  Ce contenu n’est disponible qu’en anglais.
Posté le
L’étude montre un impact limité de la pandémie sur la santé mentale, soulignant la force de la résilience humaine. Selon [...]